4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Genus plc (GNS) operates in the Biotechnology industry and is headquartered in Basingstoke, United Kingdom. Its market capitalization is roughly £1 billion.
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development.
Interactive charts & full statements → Open the GNS valuation workbench →
| Income statement | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue | — | £673M | £669M | £690M | £593M |
| Gross Profit | — | — | £179M | £188M | £148M |
| Operating Income (EBIT) | — | £42M | £6M | £44M | £51M |
| Net Income | — | £19M | £8M | £33M | £41M |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Dividends Paid | (£21M) | (£21M) | (£21M) | (£21M) |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | £899M | £988M | £966M | £1.0B |
| Total Liabilities | £423M | £474M | £430M | £446M |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GNS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms